Acromegaly Epidemiology Forecast to 2030 | Acromegaly Epidemiology Insights Report 2030 by DelveInsight

 Breaking News
  • No posts were found

Acromegaly Epidemiology Forecast to 2030 | Acromegaly Epidemiology Insights Report 2030 by DelveInsight

DelveInsight Business Research LLP
DelveInsight’s ‘Acromegaly – Epidemiology Forecast–2030’ report delivers an in-depth understanding of the Acromegaly, historical and forecasted epidemiology as well as the Acromegaly trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.

Delveinsight launched a new report on Acromegaly – Epidemiology Forecast to 2030.

Acromegaly is a hormonal disorder that results from the availability of excessive growth hormone (GH) in the body, which is produced by the pituitary gland (a small gland in the brain). In acromegaly, the pituitary produces an immoderate amount of GH, which is resulted from benign or noncancerous tumors on the pituitary. These benign tumors are called Adenomas.

The symptoms  in acromegaly vary from patient to patient. It can lead to unusual physical features, such as swollen hands and feet, deformities, and complications, with an impact also on muscle strength and bone health.

DelveInsight’s Acromegaly Epidemiology Forecast‘ report delivers an in-depth understanding of the disease, historical and forecasted Acromegaly epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

“In the US, 24,179 acromegaly cases were originated from pituitary adenomas and 1,273 from benign tumours at other sites in 2017.”

Request for sample pages:

Scope of the report:
1. The Acromegaly report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
2. The Acromegaly Epidemiology Report and Model provide an overview of the risk factors and global trends of Acromegaly in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
3. The report provides insight into the historical and forecasted patient pool of Acromegaly in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
4. The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
5. The report assesses the disease risk and burden and highlights the unmet needs of Acromegaly
6. The report provides the segmentation of the Acromegaly epidemiology

 Reasons to buy:
1. The Acromegaly Epidemiology report will allow the user to –
2. Develop business strategies by understanding the trends shaping and driving the global Acromegaly market
3. Quantify patient populations in the global Acromegaly market to improve product design, pricing, and launch plans
4. Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Acromegaly therapeutics in each of the markets covered
5. Understand the magnitude of Acromegaly population by its epidemiology
6. The Acromegaly Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Table of contents:

1. Key Insights
2. Executive Summary of Acromegaly
3. Acromegaly: Disease Background and Overview
4. Patient Journey
5. Epidemiology and Patient Population
6. Treatment Algorithm, Current Treatment, and Medical Practices
7. KOL Views
8. Unmet Needs
9.  Appendix
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight

Related reports:

Acromegaly Pipeline Insight, 2020

Acromegaly – Market Insights, Epidemiology, and Market Forecast-2030

Contact us:
Shruti Thakur
[email protected]

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States